Effect of tenofovir versus tenofovir + peginterferon on functional restoration of dendritic cells in chronic hepatitis B patients.

Trial Profile

Effect of tenofovir versus tenofovir + peginterferon on functional restoration of dendritic cells in chronic hepatitis B patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2014

At a glance

  • Drugs Tenofovir (Primary) ; Peginterferon
  • Indications Hepatitis B
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 13 Apr 2014 Results of an interim analysis presented at the 49th Annual Meeting of the European Association for the Study of the Liver
    • 11 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top